FIGURE

Fig. 7

ID

ZDB-FIG-130907-32

Publication

McCarthy et al., 2013 - Pdgfra protects against ethanol-induced craniofacial defects in a zebrafish model of FASD

Other Figures

All Figure Page

Back to All Figure Page

Fig. 7

Wortmannin or rapamycin induces pharyngeal skeleton hypoplasia in pdgfra mutants. (A-L) Embryos were treated at 10-24 hpf with (A-C) DMSO, (D-F) 1.0% ethanol, (G-I) 1.5 μM wortmannin or (J-L) 3 μM rapamycin. (M-O) Graphs depict the average area sizes, in thousands of μm² in (M) the Meckel’s (mc), (N) palatoquadrate (pq) and (O) hyosymplectic (hs) cartilages. D, DMSO; E, ethanol; W, wortmannin, R, rapamycin [standard error bars are depicted at 1.5 s.e.m., significance is indicated by non-overlapping bars (Moses, 1987)]. Wild-type, light bar; pdgfra heterozygote, light-gray bar; mutant, dark-gray bar; ch, ceratohyal. Group numbers are the same as for Fig. 6.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	pdgfra^b1059/b1059
Conditions:	chemical treatment: sirolimus chemical treatment: wortmannin
Observed In:	splanchnocranium
Stage:	Day 5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development